21
Participants
Start Date
January 15, 2016
Primary Completion Date
June 18, 2019
Study Completion Date
March 17, 2026
Aspirin
Given PO
Laboratory Biomarker Analysis
Correlative studies
Placebo Administration
Given PO
Questionnaire Administration
Ancillary studies
University of Pennsylvania/Abramson Cancer Center, Philadelphia
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Mayo Clinic in Rochester, Rochester
Northwestern University, Chicago
Kansas City Veterans Affairs Medical Center, Kansas City
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
M D Anderson Cancer Center, Houston
UCHealth University of Colorado Hospital, Aurora
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Saint Michael's Hospital, Toronto
National Cancer Institute (NCI)
NIH